Targeting cryptic splicing variants in SDCCAG8, CEP290, and ABCA4: A translational workflow from diagnosis to ASO-based therapy. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S2162253126003100?dgcid=rss_sd_all
Targeting cryptic splicing variants in SDCCAG8, CEP290, and ABCA4: A translational workflow from diagnosis to ASO-based therapy. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S2162253126003100?dgcid=rss_sd_all
“Targeting cryptic splicing variants in SDCCAG8, CEP290, and ABCA4: A translational workflow from diagnosis to ASO-based therapy.” Molecular Therapy: Nucleic Acids.
@article{article59079,
title = {Targeting cryptic splicing variants in SDCCAG8, CEP290, and ABCA4: A translational workflow from diagnosis to ASO-based therapy},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S2162253126003100?dgcid=rss_sd_all}
}